| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports.
|
Bone Marrow Transplant
|
2010
|
1.60
|
|
2
|
The probability of finding a suitable related donor for bone marrow transplantation in extended families.
|
Blood
|
1996
|
1.52
|
|
3
|
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry.
|
Leukemia
|
2000
|
1.49
|
|
4
|
Isolated HLA-C mismatches in unrelated donor transplantation for CML.
|
Bone Marrow Transplant
|
2004
|
1.12
|
|
5
|
Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation.
|
Bone Marrow Transplant
|
2007
|
1.12
|
|
6
|
How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!
|
Bone Marrow Transplant
|
2005
|
1.11
|
|
7
|
The quest for a bone marrow donor--optimal or maximal HLA matching?
|
N Engl J Med
|
1998
|
1.04
|
|
8
|
Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens.
|
Hum Immunol
|
1996
|
1.02
|
|
9
|
HLA-A, B, C, DR and DQ polymorphisms in three South African population groups: South African Negroes, Cape Coloureds and South African Caucasoids.
|
Tissue Antigens
|
1988
|
1.02
|
|
10
|
World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks.
|
Bone Marrow Transplant
|
2007
|
1.01
|
|
11
|
World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks.
|
Bone Marrow Transplant
|
2010
|
1.00
|
|
12
|
Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin.
|
J Infect Dis
|
2000
|
0.99
|
|
13
|
Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia.
|
Bone Marrow Transplant
|
2002
|
0.99
|
|
14
|
Overview of registries, HLA typing and diversity, and search algorithms.
|
Tissue Antigens
|
2007
|
0.99
|
|
15
|
Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships.
|
Bone Marrow Transplant
|
2004
|
0.95
|
|
16
|
Anti-HIV effect of iron chelators: different mechanisms involved.
|
J Clin Virol
|
2001
|
0.92
|
|
17
|
Validation of haplotype frequency estimation methods.
|
Hum Immunol
|
1998
|
0.91
|
|
18
|
Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation.
|
J Rheumatol
|
1995
|
0.90
|
|
19
|
Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?
|
Bone Marrow Transplant
|
2007
|
0.87
|
|
20
|
HLA gene haplotype frequencies in bone marrow donors worldwide registries.
|
Hum Immunol
|
1997
|
0.87
|
|
21
|
16(th) IHIW: global analysis of registry HLA haplotypes from 20 million individuals: report from the IHIW Registry Diversity Group.
|
Int J Immunogenet
|
2012
|
0.87
|
|
22
|
HLA gene and haplotype frequencies in Dutch blood donors.
|
Tissue Antigens
|
1996
|
0.86
|
|
23
|
A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA).
|
Bone Marrow Transplant
|
2004
|
0.84
|
|
24
|
Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.
|
Leukemia
|
2011
|
0.84
|
|
25
|
Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis.
|
Eur J Clin Invest
|
2002
|
0.83
|
|
26
|
The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT.
|
Bone Marrow Transplant
|
2012
|
0.83
|
|
27
|
Comparative validation of computer programs for haplotype frequency estimation from donor registry data.
|
Tissue Antigens
|
2013
|
0.83
|
|
28
|
The HLA genetic constitution of the Bushmen (San).
|
Hum Immunol
|
1990
|
0.82
|
|
29
|
Validation of large data sets, an essential prerequisite for data analysis: an analytical survey of the Bone Marrow Donors Worldwide.
|
Tissue Antigens
|
1996
|
0.82
|
|
30
|
Polymorphism of DRw52 and its association with DRw11 and DRw12 in South African blacks (Negroes) and individuals of mixed ancestry (Cape coloreds).
|
Hum Immunol
|
1990
|
0.81
|
|
31
|
A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors.
|
Tissue Antigens
|
1999
|
0.81
|
|
32
|
The HistoCheck algorithm does not predict T-cell alloreactivity in vitro.
|
Bone Marrow Transplant
|
2005
|
0.81
|
|
33
|
An update to the HLA Nomenclature Guidelines of the World Marrow Donor Association, 2012.
|
Bone Marrow Transplant
|
2013
|
0.81
|
|
34
|
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT.
|
Blood
|
1999
|
0.80
|
|
35
|
HLA frequencies in black Zimbabweans.
|
Tissue Antigens
|
1990
|
0.79
|
|
36
|
Restriction fragment length polymorphism of HLA-DRw53 detected in South African blacks and individuals of mixed ancestry.
|
Hum Immunol
|
1989
|
0.79
|
|
37
|
The importance of identifying a back-up donor for unrelated stem cell transplantation.
|
Bone Marrow Transplant
|
2005
|
0.78
|
|
38
|
The World Marrow Donor Association (WMDA): its goals and activities.
|
Bone Marrow Transplant
|
2003
|
0.78
|
|
39
|
Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data.
|
Hum Immunol
|
2001
|
0.77
|
|
40
|
A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association.
|
Hum Immunol
|
1999
|
0.77
|
|
41
|
Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre.
|
Bone Marrow Transplant
|
2009
|
0.77
|
|
42
|
A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies.
|
Bone Marrow Transplant
|
1996
|
0.77
|
|
43
|
Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.
|
Transplantation
|
2000
|
0.77
|
|
44
|
D6STNFa microsatellite locus correlates with CTLp frequency in unrelated bone marrow donor-recipient pairs.
|
Hum Immunol
|
1998
|
0.77
|
|
45
|
A study of the HLA-Dw determinants and their relationship to DR and DQ antigens in three South African population groups: South African Caucasoids, South African Negroes, and Cape coloureds.
|
Hum Immunol
|
1986
|
0.77
|
|
46
|
In vitro CTL precursor frequencies do not reflect a beneficial effect of cross-reactive group (CREG) matching.
|
Hum Immunol
|
2000
|
0.77
|
|
47
|
Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience.
|
Bone Marrow Transplant
|
1998
|
0.76
|
|
48
|
Canine mammary growth hormone gene transcription initiates at the pituitary-specific start site in the absence of Pit-1.
|
Mol Cell Endocrinol
|
1999
|
0.76
|
|
49
|
Thirty-six novel HLA alleles: 7 HLA-A, 11 HLA-B, 15 HLA-C and 3 HLA-DRB1.
|
Tissue Antigens
|
2009
|
0.75
|
|
50
|
Combining iron chelators with the nucleoside analog didanosine in anti-HIV therapy.
|
Transfus Sci
|
2000
|
0.75
|
|
51
|
An HLA matched donor! An HLA matched donor? What do you mean by: HLA matched donor?
|
Bone Marrow Transplant
|
1998
|
0.75
|
|
52
|
Bone Marrow Donors Worldwide and cord blood stem cell transplantation.
|
Bone Marrow Transplant
|
1998
|
0.75
|
|
53
|
Laboratory procedures used to select an unrelated HLA matched bone marrow donor.
|
Bone Marrow Transplant
|
1993
|
0.75
|
|
54
|
Preformed lymphocytotoxic antibodies disappear following cyclosporine therapy.
|
J Heart Transplant
|
1985
|
0.75
|
|
55
|
Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group.
|
Bone Marrow Transplant
|
2011
|
0.75
|
|
56
|
[Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors].
|
Ned Tijdschr Geneeskd
|
1997
|
0.75
|
|
57
|
A complete exon 2 sequence of the HLA-DPA1*02012 allele.
|
Tissue Antigens
|
1995
|
0.75
|
|
58
|
Role of NK cells in mismatched unrelated haematopoietic stem-cell transplantation: fact or fiction?
|
Tissue Antigens
|
2005
|
0.75
|
|
59
|
Three newly identified HLA-B alleles: B*5124, B*5306, B*5307 and confirmation of B*0809 and B*5606.
|
Tissue Antigens
|
2001
|
0.75
|
|
60
|
Five newly identified HLA alleles: A*0310, A*2907, B*4435, Cw*0206, Cw*0506, and confirmation of A*3106, B*3924, Cw*0314, DRB1*0322, and DRB1*1433 alleles.
|
Tissue Antigens
|
2004
|
0.75
|
|
61
|
[Two brothers with familial hemophagocytic lymphohistiocytosis, treated by transplantation of stem cells from a single unrelated donor].
|
Ned Tijdschr Geneeskd
|
2002
|
0.75
|
|
62
|
HLA-A,B,C, and DR antigens, GLO I and Bf marker profiles in 75 Cape coloured patients with systemic lupus erythematosus (SLE).
|
Tissue Antigens
|
1988
|
0.75
|
|
63
|
The chemotherapeutic agent bleomycin in a two-drug combination with zidovudine, ritonavir or indinavir synergistically inhibits HIV Type-1 replication in peripheral blood lymphocytes.
|
Int J Antimicrob Agents
|
2001
|
0.75
|
|
64
|
Bone marrow donors worldwide (BMDW).
|
Bone Marrow Transplant
|
1991
|
0.75
|
|
65
|
Reactivity of pretransplant cytotoxic antibodies to a selected HLA panel is not influenced by cyclosporin A, with or without plasma exchange.
|
J Clin Apher
|
1991
|
0.75
|
|
66
|
The effect of deoxynucleosides on cell proliferation of peripheral blood lymphocytes treated with deferoxamine or hydroxyurea.
|
Transfus Sci
|
2000
|
0.75
|
|
67
|
Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: report from The World Marrow Donor Association. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association.
|
Bone Marrow Transplant
|
1999
|
0.75
|
|
68
|
Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?
|
Bone Marrow Transplant
|
2003
|
0.75
|
|
69
|
An estimate on the frequency of duplicated haplotypes and silent alleles of human C4 protein polymorphism. II. Investigations in healthy Negro families.
|
Tissue Antigens
|
1994
|
0.75
|